UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058602
Receipt number R000067006
Scientific Title Investigating the Relationship Between Air Pollution and Ocular Diseases
Date of disclosure of the study information 2025/07/25
Last modified on 2025/07/25 20:23:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigating the Relationship Between Air Pollution and Ocular Diseases

Acronym

Investigating the Relationship Between Air Pollution and Ocular Diseases

Scientific Title

Investigating the Relationship Between Air Pollution and Ocular Diseases

Scientific Title:Acronym

Investigating the Relationship Between Air Pollution and Ocular Diseases

Region

Japan Asia(except Japan)


Condition

Condition

ocular disease

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to clarify the relationship between exposure to air pollutants particularly volatile organic compounds and fine particulate matter and the development or progression of ocular diseases such as age related macular degeneration dry eye disease conjunctivitis and diabetic retinopathy This research aims to evaluate both epidemiological associations and underlying biological mechanisms with a focus on oxidative stress and inflammatory responses induced by air pollution Additionally ocular surface infections will be investigated through ocular surface washes and the culture of particles collected from the eyelid margins

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1.Change in subjective symptom score (JACQLQ)
2.Changes in objective symptom score (JACQLQ)
3.Changes in conjunctival injection score
4.Identification of bacteria on the eye

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

eyewash

Interventions/Control_2

Bike commuting or car commuting

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects with ocular disease or ocular symptoms

Key exclusion criteria

1 Subjects with a past history of ocular surgery.
2. Subjects who can not use eyewash solution.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Mimura

Organization

Tsurumi University School of Dentistry

Division name

Department of Ophthalmology

Zip code

230-0063

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama City, Kanagawa, Japan

TEL

045-580-8500

Email

mimurat-tky@umin.ac.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Mimura

Organization

Tsurumi University School of Dentistry

Division name

Department of Ophthalmology

Zip code

230-0063

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama City, Kanagawa, Japan

TEL

045-580-8500

Homepage URL


Email

mimurat-tky@umin.ac.jp


Sponsor or person

Institute

Tsurumi University

Institute

Department

Personal name

Tatsuya Mimura


Funding Source

Organization

Tsurumi University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Tsurumi University Dentistry

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama City, Kanagawa, Japan

Tel

045-580-8500

Email

mimurat-tky@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

神奈川県


Institutions

Institutions

鶴見大学(神奈川県)、Rohto Laboratories Indonesia (West Jakarta City, Jakarta)、ロート製薬株式会社(京都)


Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 04 Month 01 Day

Date of IRB

2025 Year 06 Month 25 Day

Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 25 Day

Last modified on

2025 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067006